Physician profile
Robert E Gould
NPI 1972501724
$8,438.01
in general payments reported to CMS, 2019-2025
34 companies · $1,316 in 2025
The $1,316 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $977 · 2020: $556 · 2021: $1,910 · 2022: $2,098 · 2023: $1,019 · 2024: $562 · 2025: $1,316.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,897.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,896.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,600.90 | 2019-2025 | General - Pain Management, General - Therapies, Wavewriter Alpha Prime 16 |
| Abbott Laboratories | $1,303.88 | 2019-2025 | Eterna |
| Collegium Pharmaceutical, INC. | $1,157.69 | 2019-2025 | Xtampza, Belbuca |
| Spinal Simplicity, LLC | $938.99 | 2022 | |
| Nevro Corp. | $659.62 | 2019-2024 | Senza |
| Abbvie INC. | $558.32 | 2022-2025 | |
| Medtronic, INC. | $352.47 | 2021-2025 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray |
| Medtronic USA, INC. | $331.54 | 2019 | |
| Spr Therapeutics, INC | $226.51 | 2019-2021 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $175.26 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $170.92 | 2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $136.03 | 2020-2025 | Relistor |
| Biodelivery Sciences International, INC. | $132.96 | 2020-2021 | |
| Biohaven Pharmaceuticals, INC. | $116.81 | 2021 | |
| Pfizer INC. | $92.70 | 2019-2024 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $53.84 | 2020-2022 | |
| Almatica Pharma LLC | $43.80 | 2022 | |
| Amgen INC. | $42.59 | 2021-2022 | |
| Biotronik Nro, INC. | $37.43 | 2025 | Prospera |
| Globus Medical, INC. | $36.16 | 2025 | Senza, Vyrsa V1 |
| Pacira Pharmaceuticals Incorporated | $34.70 | 2023 | Zilretta, Iovera, Exparel |
| Baudax Bio INC. | $32.92 | 2021-2022 | |
| Ipsen Biopharmaceuticals, INC | $21.86 | 2020 | |
| Hikma Pharmaceuticals USA | $21.00 | 2022 | |
| Curonix LLC | $19.75 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Radius Health, INC. | $19.73 | 2025 | Tymlos |
| Protega Pharmaceutials INC | $18.53 | 2022 | |
| Saluda Medical Americas, INC. | $17.29 | 2025 | Evoke |
| Scilex Pharmaceuticals INC. | $17.25 | 2019 | |
| Zyla Life Sciences, INC. | $16.75 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $14.96 | 2023 | Seglentis |
| Fidia Pharma USA INC. | $13.80 | 2020 | |
| Daiichi Sankyo INC. | $13.39 | 2019 | |
| Nalu Medical, INC. | $7.66 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Gould listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.